Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Munschauer

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Neurology|May 16, 2008
Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patientsR H B Benedict, F Munschauer, P Zarevics, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2008
Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis opticaB Weinstock-Guttman, C Miller, Ea Yeh, et al.
Journal of Clinical Immunology|July 15, 1999
Flow cytometric analysis of in vitro proinflammatory cytokine secretion in peripheral blood from multiple sclerosis patientsL T Nguyen, M Ramanathan, F Munschauer, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1994
Pentoxifylline and meclofenamic acid treatment reduces clinical manifestations in a murine model of AIDSI Stadler, K C Chadha, S Nakeeb, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 30, 2003
Pattern reversal visual evoked potentials as a measure of visual pathway pathology in multiple sclerosisB Weinstock-Guttman, M Baier, R Stockton, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 29, 2008
Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severityZ Sternberg, B Weinstock-Guttman, D Hojnacki, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Neurology|May 16, 2008
Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patientsR H B Benedict, F Munschauer, P Zarevics, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2008
Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis opticaB Weinstock-Guttman, C Miller, Ea Yeh, et al.
Journal of Clinical Immunology|July 15, 1999
Flow cytometric analysis of in vitro proinflammatory cytokine secretion in peripheral blood from multiple sclerosis patientsL T Nguyen, M Ramanathan, F Munschauer, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1994
Pentoxifylline and meclofenamic acid treatment reduces clinical manifestations in a murine model of AIDSI Stadler, K C Chadha, S Nakeeb, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 30, 2003
Pattern reversal visual evoked potentials as a measure of visual pathway pathology in multiple sclerosisB Weinstock-Guttman, M Baier, R Stockton, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 29, 2008
Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severityZ Sternberg, B Weinstock-Guttman, D Hojnacki, et al.
Pageof 2